Notice2022-04425
National Institute of General Medical Sciences; Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 3, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 42 (Thursday, March 3, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 42 (Thursday, March 3, 2022)]
[Notices]
[Page 12181]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-04425]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Review of Institutional Development
Award (IDeA) Program Infrastructure for Clinical and Translational
Research (IDeA-CTR) (U54).
Date: March 30, 2022.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of General Medical Science, Natcher
Bldg. 45, 45 Center Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Saraswathy Seetharam, Ph.D., Scientific Review
Officer, Office Scientific Review, National Institute of General
Medical Sciences, National Institutes Health, 45 Center Drive, Room
3AN12C, Bethesda, MD 20892, 301-594-2763, <a href="/cdn-cgi/l/email-protection#1063757564787162717d63507e79777d633e7e79783e777f66"><span class="__cf_email__" data-cfemail="1b687e7e6f737a697a76685b75727c766835757273357c746d">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859, Biomedical Research and
Research Training, National Institutes of Health, HHS)
Dated: February 25, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-04425 Filed 3-2-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 3, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.